STOCK TITAN

[Form 3] BIOVIE INC. Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3
Rhea-AI Filing Summary

BioVie Inc. (BIVI) filed a Form 3, the initial statement of beneficial ownership for a board member. The reporting person is a Director, and the filing states that no securities are beneficially owned as of the event date 07/17/2025. The form indicates it was filed by one reporting person. This is a routine ownership disclosure that establishes the insider’s baseline holdings at the time of becoming subject to reporting.

BioVie Inc. (BIVI) ha presentato un Modulo 3, la dichiarazione iniziale di titolarità beneficiaria per un membro del consiglio. Il soggetto che riporta è un Direttore, e la dichiarazione indica che nessun titolo è detenuto beneficiariamente alla data dell'evento 07/17/2025. Il modulo indica che è stato presentato da un solo soggetto reportante. Questa è una disclosure di proprietà di routine che stabilisce le partecipazioni di base dell insider al momento della sua entrata nell obbligo di segnalazione.

BioVie Inc. (BIVI) presentó un Formulario 3, la declaración inicial de titularidad beneficiosa para un miembro de la junta. La persona que reporta es un Director, y el formulario indica que no posee valores de forma beneficiosa a la fecha del evento 07/17/2025. El formulario indica que fue presentado por una sola persona reportante. Esta es una divulgación de propiedad de rutina que establece las participaciones básicas del insider en el momento de convertirse en sujeto a la divulgación.

BioVie Inc. (BIVI) 가 Form 3 을 제출했습니다, 이사회 구성원을 위한 초기 이익 소유 진술서입니다. 보고자는 이사이며, 사건 날짜인 2025-07-17 현재 이익 소유로 보유한 증권이 없다고 명시되어 있습니다. 양식은 한 명의 보고자가 이를 제출했다고 표시합니다. 이것은 보고 의무가 시작될 때 내부자의 기본 보유를 설정하는 일상적인 소유권 공시입니다.

BioVie Inc. (BIVI) a déposé un Formulaire 3, la déclaration initiale de titularité bénéficiaire pour un membre du conseil d administration. La personne déclarant est un Administrateur, et le formulaire indique qu’aucun titre n’est détenu bénéficiairement à la date de l’événement 17/07/2025. Le formulaire indique qu’il a été déposé par une seule personne déclarant. Il s’agit d’une divulgation routinière de propriété qui établit les avoirs de base de l’insider au moment où il devient soumis à la divulgation.

BioVie Inc. (BIVI) hat ein Formular 3 eingereicht, die anfängliche Offenlegung des wirtschaftlichen Eigentums für ein Vorstandsmitglied. Die meldende Person ist ein Direktor, und das Formular gibt an, dass zum Ereignisdatum 07/17/2025 keine Wertpapiere wirtschaftlich beteiligt sind. Das Formular gibt an, dass es von einer meldenden Person eingereicht wurde. Dies ist eine routinemäßige Offenlegung des Eigentums, die die Basisholdings des Insider zum Zeitpunkt der Berichtspflicht festlegt.

BioVie Inc. (BIVI) قدمت نموذج 3, التصريح الأول عن الملكية المستفيدة لعضو في المجلس. الشخص المبلغ هو مدير، ويذكر النموذج أن لا توجد أسهم مملوكة بشكل مستفيد حتى تاريخ الحدث 17/07/2025. يشير النموذج إلى أنه قد تم تقديمه بواسطة شخص واحد مقدم التقرير. هذه إفشاء ملكية روتيني يحدد الحيازة الأساسية للمطلع حين يصبح خاضعاً للإبلاغ.

Positive
  • None.
Negative
  • None.

BioVie Inc. (BIVI) ha presentato un Modulo 3, la dichiarazione iniziale di titolarità beneficiaria per un membro del consiglio. Il soggetto che riporta è un Direttore, e la dichiarazione indica che nessun titolo è detenuto beneficiariamente alla data dell'evento 07/17/2025. Il modulo indica che è stato presentato da un solo soggetto reportante. Questa è una disclosure di proprietà di routine che stabilisce le partecipazioni di base dell insider al momento della sua entrata nell obbligo di segnalazione.

BioVie Inc. (BIVI) presentó un Formulario 3, la declaración inicial de titularidad beneficiosa para un miembro de la junta. La persona que reporta es un Director, y el formulario indica que no posee valores de forma beneficiosa a la fecha del evento 07/17/2025. El formulario indica que fue presentado por una sola persona reportante. Esta es una divulgación de propiedad de rutina que establece las participaciones básicas del insider en el momento de convertirse en sujeto a la divulgación.

BioVie Inc. (BIVI) 가 Form 3 을 제출했습니다, 이사회 구성원을 위한 초기 이익 소유 진술서입니다. 보고자는 이사이며, 사건 날짜인 2025-07-17 현재 이익 소유로 보유한 증권이 없다고 명시되어 있습니다. 양식은 한 명의 보고자가 이를 제출했다고 표시합니다. 이것은 보고 의무가 시작될 때 내부자의 기본 보유를 설정하는 일상적인 소유권 공시입니다.

BioVie Inc. (BIVI) a déposé un Formulaire 3, la déclaration initiale de titularité bénéficiaire pour un membre du conseil d administration. La personne déclarant est un Administrateur, et le formulaire indique qu’aucun titre n’est détenu bénéficiairement à la date de l’événement 17/07/2025. Le formulaire indique qu’il a été déposé par une seule personne déclarant. Il s’agit d’une divulgation routinière de propriété qui établit les avoirs de base de l’insider au moment où il devient soumis à la divulgation.

BioVie Inc. (BIVI) hat ein Formular 3 eingereicht, die anfängliche Offenlegung des wirtschaftlichen Eigentums für ein Vorstandsmitglied. Die meldende Person ist ein Direktor, und das Formular gibt an, dass zum Ereignisdatum 07/17/2025 keine Wertpapiere wirtschaftlich beteiligt sind. Das Formular gibt an, dass es von einer meldenden Person eingereicht wurde. Dies ist eine routinemäßige Offenlegung des Eigentums, die die Basisholdings des Insider zum Zeitpunkt der Berichtspflicht festlegt.

BioVie Inc. (BIVI) قدمت نموذج 3, التصريح الأول عن الملكية المستفيدة لعضو في المجلس. الشخص المبلغ هو مدير، ويذكر النموذج أن لا توجد أسهم مملوكة بشكل مستفيد حتى تاريخ الحدث 17/07/2025. يشير النموذج إلى أنه قد تم تقديمه بواسطة شخص واحد مقدم التقرير. هذه إفشاء ملكية روتيني يحدد الحيازة الأساسية للمطلع حين يصبح خاضعاً للإبلاغ.

BioVie Inc. (BIVI) 提交了 Form 3,用于董事会成员的初始受益所有权申报。申报人是一名 董事,申报指出在事件日期 07/17/2025 时没有任何以受益方式持有的证券。表格指明是由一名申报人提交。これは一种常规的所有权披露,用于在内幕人士进入需要披露之时确立其基线持股。

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Farag Kameel D.

(Last) (First) (Middle)
C/O BIOVIE INC.
680 W NYE LANE STE. 201

(Street)
CARSON CITY NV 89703

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
07/17/2025
3. Issuer Name and Ticker or Trading Symbol
BIOVIE INC. [ BIVI ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
No securities are beneficially owned.
/s/ Joanne Wendy Kim, attorney-in-fact for Kameel D. Farag 10/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did BioVie (BIVI) disclose in this Form 3?

The filing reports that a Director has no securities beneficially owned as of 07/17/2025.

Who is the reporting person on the BIVI Form 3?

The signature indicates filing by Joanne Wendy Kim, attorney-in-fact for Kameel D. Farag.

What is the relationship of the reporting person to BioVie (BIVI)?

The reporting person is a Director.

How many reporting persons are included in this filing?

It is filed by one reporting person.

What is the event date for the holdings reported?

The event date is 07/17/2025.

Does the Form 3 list any derivative or non-derivative holdings?

No. The filing states: “No securities are beneficially owned.”
Biovie Inc

NASDAQ:BIVI

BIVI Rankings

BIVI Latest News

BIVI Latest SEC Filings

BIVI Stock Data

14.02M
7.28M
3.28%
1.53%
2.3%
Biotechnology
Pharmaceutical Preparations
Link
United States
CARSON CITY